Literature DB >> 16523272

[Scleromyxedema].

G Kukova1, D Bruch-Gerharz, K Gensch, T Ruzicka, J Reifenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16523272     DOI： 10.1007/s00105-006-1113-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  4 in total

1.  Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.

Authors:  A Karim; F Lawlor; M M Black
Journal:  Clin Exp Dermatol       Date:  2004-05       Impact factor: 3.470

2.  A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema.

Authors:  Keren B Horn; Meyer A Horn; James Swan; Seema Singhal; Joan Guitart
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

3.  Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Authors:  Michele L Donato; Adrienne M Feasel; Donna M Weber; Victor G Prieto; Sergio A Giralt; Richard E Champlin; Madeleine Duvic
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

4.  Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.

Authors:  Julia C Sansbury; Barbara Cocuroccia; Joseph L Jorizzo; Emanuela Gubinelli; Paolo Gisondi; Giampiero Girolomoni
Journal:  J Am Acad Dermatol       Date:  2004-07       Impact factor: 11.527
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.